abiraterone accord
accord healthcare s.l.u. - абаратер ацетат - Простатни неоплазми - Ендокринна терапия - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
imatinib synthon 100 mg capsules
synthon bv - imatinib - 100 mg capsules
bortezomib synthon 3,5 mg powder for sol.
synthon bv - Бортезомиб - 3,5 mg powder for sol.
imatinib synthon 100 mg film - coated tablets
synthon bv - 100 mg film - coated tablets
imatinib synthon 400 mg film - coated tablets
synthon bv - 400 mg film - coated tablets
ibandronic acid synthon 150 mg film - coated tablets
synthon bv - 150 mg film - coated tablets
sevelamer carbonate synthon 800 mg film - coated tablets
synthon bv - 800 mg film - coated tablets
anagrelide mylan
mylan pharmaceuticals limited - anagrelide хидрохлорид - Тромбоцитемия, съществено - Антинеопластични средства - anagrelide е показан за понижаване на повишени нива на тромбоцитите при значително thrombocythaemia на риска (ет) пациенти, които имат непоносимост към текущата терапия или които да вдигна нивото на тромбоцитите не е намален до приемливо ниво ги сегашната терапия. an at-risk patientan at-risk essential thrombocythaemia patient is defined by one or more of the following features:>60 years of age ora platelet count >1,000 x 10⁹/l ora history of thrombo-haemorrhagic events.
voriconazole syntbon 50 mg film - coated tablets
synthon bv - вориконазол - 50 mg film - coated tablets
voriconazole syntbon 200 mg film - coated tablets
synthon bv - вориконазол - 200 mg film - coated tablets